• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate.

作者信息

Giuliani Jacopo, Bonetti Andrea

机构信息

Department of Oncology, Mater Salutis Hospital-ASL 21 della Regione Veneto, Legnago (VR), Italy.

出版信息

Chin J Cancer Res. 2013 Oct;25(5):486-7. doi: 10.3978/j.issn.1000-9604.2013.10.13.

DOI:10.3978/j.issn.1000-9604.2013.10.13
PMID:24255568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3828449/
Abstract
摘要

相似文献

1
Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate.甲磺酸伊马替尼引入前后的胃肠道间质瘤和第二原发性恶性肿瘤
Chin J Cancer Res. 2013 Oct;25(5):486-7. doi: 10.3978/j.issn.1000-9604.2013.10.13.
2
Efficacy of surgery and imatinib mesylate in the treatment of advanced gastrointestinal stromal tumor: a systematic review.手术和甲磺酸伊马替尼治疗晚期胃肠道间质瘤的疗效：一项系统评价
Tumori. 2010 May-Jun;96(3):392-9. doi: 10.1177/030089161009600303.
3
Pathological complete response in advanced gastric stromal tumor after imatinib mesylate therapy: a case report.甲磺酸伊马替尼治疗晚期胃间质瘤后的病理完全缓解：一例报告
J Med Case Rep. 2011 May 21;5:197. doi: 10.1186/1752-1947-5-197.
4
Advanced gastrointestinal stromal tumors successfully treated with imatinib mesylate: a report of two cases.甲磺酸伊马替尼成功治疗晚期胃肠道间质瘤：两例报告
J Natl Med Assoc. 2003 Dec;95(12):1208-10.
5
Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment.晚期胃肠道间质瘤（GIST）患者在甲磺酸伊马替尼治疗期间的基因变化。
Langenbecks Arch Surg. 2006 Nov;391(6):615-21. doi: 10.1007/s00423-006-0103-z. Epub 2006 Oct 6.
6
Prospective observational study of imatinib therapy in Japanese patients with advanced gastrointestinal stromal tumors: long-term follow-up and second malignancy.前瞻性观察性研究伊马替尼治疗晚期胃肠间质瘤的日本患者：长期随访和第二恶性肿瘤。
Jpn J Clin Oncol. 2012 Jul;42(7):578-85. doi: 10.1093/jjco/hys056. Epub 2012 Apr 21.
7
Gastrointestinal stromal tumor (GIST) and imatinib.胃肠道间质瘤（GIST）与伊马替尼
Int J Clin Oncol. 2006 Jun;11(3):184-9. doi: 10.1007/s10147-006-0579-0.
8
ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.ACRIN 6665/RTOG 0132 期临床试验：新辅助甲磺酸伊马替尼治疗可切除的恶性胃肠道间质瘤：18F-FDG PET 监测及其与基因型和 GLUT4 表达的相关性。
J Nucl Med. 2012 Apr;53(4):567-74. doi: 10.2967/jnumed.111.094425. Epub 2012 Mar 1.
9
Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor.甲磺酸伊马替尼与AKT抑制剂联合使用在胃肠道间质瘤临床前研究中具有协同作用。
Clin Cancer Res. 2017 Jan 1;23(1):171-180. doi: 10.1158/1078-0432.CCR-16-0529. Epub 2016 Jul 1.
10
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.胃肠道间质瘤的基因表达谱和对甲磺酸伊马替尼的反应。
Mol Cancer Ther. 2009 Aug;8(8):2172-82. doi: 10.1158/1535-7163.MCT-09-0193. Epub 2009 Aug 11.

引用本文的文献

1
Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive-resistant differentiated thyroid cancer.多激酶抑制剂/仑伐替尼在同时性/异时性合并放射性抵抗分化型甲状腺癌的癌症患者中的应用。
Cancer Med. 2022 Oct;11 Suppl 1(Suppl 1):26-32. doi: 10.1002/cam4.5107.
2
Significance of Primary Malignant Tumors on the Outcome of Patients With Resected Gastrointestinal Stromal Tumors.原发恶性肿瘤对胃肠道间质瘤患者术后生存的意义。
In Vivo. 2020 May-Jun;34(3):1201-1205. doi: 10.21873/invivo.11893.
3
Frequency, localization, and types of gastrointestinal stromal tumor-associated neoplasia.胃肠道间质瘤相关肿瘤的发生频率、定位和类型。
World J Gastroenterol. 2019 Aug 14;25(30):4261-4277. doi: 10.3748/wjg.v25.i30.4261.
4
The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies.胃肠道间质瘤与第二原发性恶性肿瘤的发生
J Gastrointest Cancer. 2015 Dec;46(4):408-12. doi: 10.1007/s12029-015-9759-3.
5
Criminal or bystander: imatinib and second primary malignancy in GIST patients.罪犯还是旁观者：伊马替尼与胃肠道间质瘤患者的第二原发性恶性肿瘤
Chin J Cancer Res. 2013 Oct;25(5):490-2. doi: 10.3978/j.issn.1000-9604.2013.10.15.

本文引用的文献

1
Prospective observational study of imatinib therapy in Japanese patients with advanced gastrointestinal stromal tumors: long-term follow-up and second malignancy.前瞻性观察性研究伊马替尼治疗晚期胃肠间质瘤的日本患者：长期随访和第二恶性肿瘤。
Jpn J Clin Oncol. 2012 Jul;42(7):578-85. doi: 10.1093/jjco/hys056. Epub 2012 Apr 21.
2
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies.酪氨酸激酶抑制剂（TKI）治疗慢性髓性白血病（CML）和其他血液系统恶性肿瘤过程中出现的恶性肿瘤。
Blood. 2011 Oct 20;118(16):4353-8. doi: 10.1182/blood-2011-06-362889. Epub 2011 Aug 16.
3
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.甲磺酸伊马替尼治疗伴有 c-Kit 突变或扩增的转移性黑色素瘤患者的 II 期、开放标签、单臂试验。
J Clin Oncol. 2011 Jul 20;29(21):2904-9. doi: 10.1200/JCO.2010.33.9275. Epub 2011 Jun 20.
4
KIT as a therapeutic target in metastatic melanoma.KIT 作为转移性黑色素瘤的治疗靶点。
JAMA. 2011 Jun 8;305(22):2327-34. doi: 10.1001/jama.2011.746.
5
Metastatic gastrointestinal stromal tumors in the era of imatinib: improved survival and elimination of socioeconomic survival disparities.伊马替尼时代的转移性胃肠道间质瘤：生存率提高及社会经济生存差距的消除
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2194-201. doi: 10.1158/1055-9965.EPI-08-0237.
6
Occurrence of other malignancies in patients with gastrointestinal stromal tumors.胃肠道间质瘤患者中其他恶性肿瘤的发生情况。
Semin Diagn Pathol. 2006 May;23(2):120-9. doi: 10.1053/j.semdp.2006.09.004.
7
Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.胃肠道间质瘤等胃肠道间质肿瘤的当前发病率及治疗结果。
J Am Coll Surg. 2006 Apr;202(4):623-9. doi: 10.1016/j.jamcollsurg.2006.01.002.
8
Small gastrointestinal stromal tumor concomitant with early gastric cancer: a case report.小胃肠间质瘤合并早期胃癌：一例报告
World J Gastroenterol. 2006 Feb 7;12(5):815-7. doi: 10.3748/wjg.v12.i5.815.
9
Synchronous primary adenocarcinoma, mucosa-associated lymphoid tissue lymphoma and a stromal tumor in a Helicobacter pylori-infected stomach.幽门螺杆菌感染的胃中出现的同步原发性腺癌、黏膜相关淋巴组织淋巴瘤和间质瘤。
J Gastroenterol Hepatol. 2002 Sep;17(9):1033-6. doi: 10.1046/j.1440-1746.2002.02649.x.
10
ARG tyrosine kinase activity is inhibited by STI571.ARG酪氨酸激酶活性被STI571抑制。
Blood. 2001 Apr 15;97(8):2440-8. doi: 10.1182/blood.v97.8.2440.